Celera Revenues Up as Loss Declines in Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its first-quarter revenues increased 16 percent, while the firm cut its net loss significantly on lower charges year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $45.7 million for the three-month period ended March 28, compared to revenues of $39.5 million for the first quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.